ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
36 announcements with these filters
Hexagon Nutrition intimated a board meeting on 14 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes from 01 Oct until 48 hours after results declaration.
Hexagon Nutrition shareholders approved Arun Purushottam Kelkar as Executive Director and Chairman, effective October 28, 2026. He has been with the company since its incorporation.
Hexagon Nutrition held its EGM on 28 October 2026 and summarised proceedings. Resolutions covered appointment of Arun Kelkar as Executive Director and Chairman, plus related remuneration approvals.
Hexagon Nutrition Ltd has filed its quarterly shareholding pattern report for the period ending September 30, 2026, as required by SEBI regulations.
Hexagon Nutrition dispatched letters to shareholders with unregistered email addresses, providing a web link to access the Notice of the upcoming Extra Ordinary General Meeting.
Hexagon Nutrition Limited has issued a notice for an Extraordinary General Meeting scheduled for October 28, 2026, to seek shareholder approval for director appointments and remuneration.
Hexagon Nutrition has launched 'PFH-VAP', a stable formulation of Vitamin A Palmitate, across the African international market.
Hexagon Nutrition successfully completed commercial-scale process validation for its PFH-VAP (Vitamin A Palmitate) formulation. The company will now proceed with steps for commercializing the product under "VIT A+".
Hexagon Nutrition Ltd has scheduled a Board Meeting for September 30, 2026, to discuss requisition letters for appointing directors and approving remuneration.
Hexagon Nutrition Limited announced the appointment of an Executive Director, re-appointment of a Joint Managing Director, and the appointment of a Secretarial Auditor.
Hexagon Nutrition informed exchanges that its promoters abstained from voting on certain resolutions. The company is currently seeking independent legal advice regarding this matter.
Hexagon Nutrition Limited held its 33rd Annual General Meeting on September 22, 2026. The meeting transacted business as listed in the AGM notice.
Promoters and promoter group members of Hexagon Nutrition Ltd purchased 40,000 equity shares via open market transactions, with a total consideration of ₹0.26 Crore.
Dr. Nikhil Kelkar, promoter and joint MD of Hexagon Nutrition, acquired 10,000 equity shares in the open market. His stake rose from 17.27% to 17.28%.
Hexagon Nutrition Limited has intimated the stock exchanges regarding the dispatch of a communication providing a web-link for the 33rd Annual General Meeting and Annual Report.
Hexagon Nutrition received a Customs order demanding payment of Rs. 1.05 Crore, including duty and penalties. The Company intends to file an appeal against the findings.
Hexagon Nutrition Ltd has scheduled its 33rd Annual General Meeting for September 22, 2026, and released the Annual Report for the Financial Year 2025-26.
Hexagon Nutrition delivered strong Q1 FY27 results with 43.2% revenue growth and 25.1% PAT growth. Management focused on expanding the branded portfolio and optimizing capacity utilization.
Anuradha Arun Kelkar, a promoter group member of Hexagon Nutrition Ltd, acquired 15,000 equity shares via open market. This transaction increased her stake from 7.37% to 7.38%.
Hexagon Nutrition reported Q1 FY27 revenue of ₹1,043 Mn with 11.3% EBITDA margin. The firm focuses on specialized clinical and wellness nutrition brands like Pentasure and Pediagold.
Hexagon Nutrition reported Q1 FY27 revenue of ₹104.3 crore, a 43.2% YoY growth. Profit after tax rose 25.1% to ₹8.1 crore.
Hexagon Nutrition announced the appointment of Mr. Raghunath Sawant and re-appointment of Mr. Arun Purushottam Kelkar as Executive Directors for a five-year term.
Hexagon Nutrition Limited has appointed Mr. Raghunath Sawant as Executive Director and re-appointed Mr. Arun Purushottam Kelkar as Executive Director.
Hexagon Nutrition Limited has issued the notice for its 33rd Annual General Meeting scheduled for September 22, 2026. The meeting agenda includes dividend declaration and director appointments.
Hexagon Nutrition Limited board approved a final dividend of ₹0.30 per equity share for the financial year 2025-2026. The record date is September 15, 2026.
Hexagon Nutrition Ltd reported revenue from operations of ₹104.3 Cr (+43.1% YoY) and net profit of ₹8.1 Cr (+24.6% YoY) for Q1 FY27.
Hexagon Nutrition Limited has scheduled a board meeting for August 12, 2026, to consider quarterly financial results and potential dividend declarations.
Hexagon Nutrition Ltd has appointed CARE Ratings Ltd as its new credit rating agency. The agency has assigned 'CARE A-; Stable' ratings to its bank facilities.
Hexagon Nutrition reported strong FY26 performance with 17.8% revenue growth to ₹382.63 Cr and PAT surge of 56.1%. Focus remains on high-margin branded products and export expansion.
Hexagon Nutrition Ltd has filed its quarterly shareholding pattern as per SEBI regulations, detailing the distribution of equity among promoters and the public.